BNCC *Plasmodium falciparum* Biological Quality Control Product: Strengthening the Front Line of Malaria Detection

Malaria is a vector-borne infectious disease targeted for priority prevention and control. Among the causative agents, *Plasmodium falciparum* is the most virulent and lethal; infections progress rapidly, often leading to severe complications such as high fever and organ damage, and can be life-threatening if not treated promptly.

This parasite is primarily transmitted through the bites of female *Anopheles* mosquitoes, though indirect transmission can also occur via blood transfusion or mother-to-child transmission. Given the insidious nature of transmission and the rapid onset of the disease, accurate nucleic acid testing is crucial for malaria control, while high-quality control products are essential for ensuring data accuracy and standardized testing procedures.

Product Introduction

BNCC has launched a new *Plasmodium falciparum* biological quality control product (nucleic acid control/DNA standard). Prepared in accordance with public health testing standards and utilizing a genuine pathogen matrix, this product is suitable for quality control in molecular testing, method validation, and laboratory proficiency testing, making it fully compatible with a wide range of precision testing applications.

Key Product Advantages

1. Precise Targeting and High Specificity: Well-defined sequences with no cross-reactivity, significantly enhancing detection accuracy.

2. Stable Matrix and Batch Consistency: Produced via standardized processes with minimal batch-to-batch variation, ensuring excellent experimental reproducibility.

3. Broad Compatibility and Ease of Use: Compliant with industry standards and compatible with various laboratory workflows; requires no complex pre-treatment.

Applications

·Centers for Disease Control (CDC): Malaria outbreak surveillance, laboratory proficiency testing, and quality control calibration.

·Medical Testing Laboratories: Clinical malaria screening and routine internal quality control.

·IVD Companies: Development, performance validation, and process optimization of *Plasmodium* detection reagents.

·Research Institutions and Universities: *Plasmodium*-related research and experiments on innovative detection methods.